Qrativ

One Main St Ste 400
Cambridge
MA
02142
help@nference.net
Category 
Digital Health Company
Region 
Metro Boston
Qrativ is reinventing the way treatments for diseases with unmet medical need are discovered and developed. Starting in the early stages of drug development, Qrativ partners can leverage the company's drug purposing platform, Darwin.ai, to search for all possible uses of a drug candidate, including identifying potential rare disease indications and find subsets of patients who may respond favorably to a given candidate. Qrativ aims to maximize every drug's potential for as many patients and diseases as possible.
Buyer 
Pharma
Setting 
Other
User 
Pharma
Purpose 
Clinical Research
Method 
Artificial Intelligence / Predictive Analytics / Machine Learning